07.11.2016 - Aktuelles

IMPROVING THE APPLICABILITY OF DRUG TRIALS TO WOMEN

November 30th – December 1st, 2016
Berlin (Germany)

The Matera Resolution was drafted in April 2016 by an inaugural group of advocates to create a strategy to improve the evidence base and applicability of drug trial results to women in real world settings.

The purpose of the Matera group meeting is to refine the strategy and develop recommendations to advocates and create a strategy to improve the evidence base and applicability of drug trial results to women in real world settings.

Recent research evidence and the various activities launched with different stakeholders, including regulatory and funding organizations, journal editors, government agencies, industry and patient sectors will be discussed.

 

 

Presidents of the Meeting
Prof. Flavia Franconi
Prof. Vera Regitz-Zagrosek
Prof. Cara Tannenbaum

 

Organized by:

Charité - Universitätsmedizin Berlin
Institute of Gender in Medicine (GIM)
Deutsche Gesellschaft für Geschlechtsspezifische Medizin e.V. (DGesGM)
CIHR Institute of Gender and Health

 

 

Downloads:

Kontakt:

Prof.Dr.med. Vera Regitz-Zagrosek

VRZ

Direktorin des GiM

Charité - Universitätsmedizin Berlin

Berliner Institut für Geschlechterforschung in der Medizin (GiM)

Center for Cardiovascular Research (CCR)

Postadresse:

Hessische Straße 3-4

10115 Berlin

t: +49 30 450 525 -172/-288

f: +49 30 450 7 525 288



zurück zur Übersicht

Weitere Nachrichten

...aus der Charité finden Sie im Pressebereich.